Non-Small Cell Lung Cancer

CDK patent granted to Cyclacel

CDK patent granted to Cyclacel

Cyclacel has received a US patent that covers a novel series of
pyrimidine small molecules shown to inhibit the progress of cells
through the cancer cell cycle. The patented compounds may be useful
as therapeutics for cancer, inflammatory...


Follow us


View more


Featured Suppliers

All suppliers